Clinical trial
Ondansetron for the Treatment of Methamphetamine Dependence - 1
NCT00040053 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00040053 |
|---|---|
| Title | Ondansetron for the Treatment of Methamphetamine Dependence - 1 |
| Official title | Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence. |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Texas |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amphetamine-Related Disorders |
| Intervention type | Drug |
| Interventions | Ondansetron |
| Enrollment | 154 |
| Start date | Jun 1, 2002 |
| Completion | Feb 1, 2004 |
| First posted | Jun 18, 2002 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: